KRIYA-586

N/A

Report date: 2024/01/12 09:42:07

Base Information

Drug NameKRIYA-586

Drug Alias NameKRIYA-586

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionAnti-Insulin-like growth factor I receptor

TargetsInsulin-like growth factor I receptor

Therapy Area/IndicationsGraves Ophthalmopathy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesKriya Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesKriya Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsGraves Ophthalmopathy

Inactive IndicationsN/A

Other Information

ATC CodeN/A